乙肝肝硬化患者血清IFN-及相关因子水平与肝脏炎症活动的关系

表1 各组IFN-、IL-2及sIL-2R浓度(mean±SD, pg/mL)

组别	IFN-	IL-2	SIL-2R
NC组	21.213±5.876	5.404±2.161	94.917±83.672
SLC组	23.619±8.183d	6.003±2.174d	380.571±290.107bd
ALC组	35.881±9.032b	11.989±7.232b	848.656±368.105b

^aP<0.05,

^bP<0.01 vs NC组;

^dP<0.01 vs ALC组.

表2 IFN-、IL-2及sIL-2R浓度与乙肝病毒标志物HBeAg(mean±SD, pg/mL)

	n	IFN-	IL-2	SIL-2R
HBeAg(+)	6	21.635±2.007a	4.754±1.836	663.021±278.722
HBeAg(-)	37	30.569±10.800	9.441±6.125	587.787±420.064

^aP<0.05 vs HBeAg(-)组.

表3 IFN-、IL-2及sIL-2R浓度与ALT及SB的相关性

	IFN-	IL-2	sIL2-R
ALT	r = 0.339a	r = 0.119	r = 0.324a
SB	r = 0.287	r = 0.517a	r = 0.455a
IFN-		r = 0.324a	r = 0.177
IL-2			r = 0.263

^aP<0.05.